Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07645430
NA

Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.

Sponsor: Benha University

View on ClinicalTrials.gov

Summary

The primary objective of this study was to evaluate the change in serum interferon gamma and Interleukin-15 levels before and after use of oral drug baricitinib therapy. Venous blood samples (5 mL) were collected from each participant at baseline and at six months.

Official title: Assessment of Serum Level of Interleukin-15 and Interferon Gamma in Alopecia Areata Patients Before and After Baricitinib Treatment

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2023-01-01

Completion Date

2026-06-09

Last Updated

2026-06-12

Healthy Volunteers

No

Conditions

Interventions

DRUG

Baricitinib 4 MG Oral Tablet

All cases will use oral Baricitinab 4mg daily dose for six months.

Locations (1)

Faculty of medicine, Benha University (Dermatology department)

Banhā, Egypt